Instadose Pharma Corp. (INSD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 17, 2026, 9:30 AM EST
Instadose Pharma Market Cap
Instadose Pharma has a market cap or net worth of $532 as of February 18, 2026.
Market Cap
532.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 4, 2022, Instadose Pharma's market cap has decreased from 206.26M to 532.00, a decrease of -100.00%. That is a compound annual growth rate of -95.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 532.00 | -99.00% |
| Dec 30, 2025 | 53.19K | -99.97% |
| Jan 4, 2022 | 206.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Item 9 Labs | 702.00 |
| Beleave | 554.00 |
| Radient Technologies | 541.00 |
| OWC Pharmaceutical Research | 497.00 |
| TRANSNATIONAL CANNABIS LTD | 492.00 |
| Abattis Bioceuticals | 476.00 |
| Flower One Holdings | 473.00 |
| Choom Holdings | 467.00 |